<DOC>
	<DOCNO>NCT02508857</DOCNO>
	<brief_summary>Magnesium sulfate report improve postoperative pain , evidence still controversial . Some study demonstrate benefit others conclude efficacy . Aim : aim study compare effect intravenous infusion magnesium sulfate ketorolac laparoscopic gynecologic oncology surgery . Methods : We design double-blind randomized control trial compare intravenous magnesium sulfate ketorolac saline solution postoperative pain , morphine consumption opioid related side effect .</brief_summary>
	<brief_title>Magnesium Sulfate Improves Postoperative Analgesia Laparoscopic Gynecologic Surgeries</brief_title>
	<detailed_description>Sixty American Society Anesthesiologists ( ASA ) I-II patient undergo laparoscopic gynecologic oncology surgery enrol study . Patients randomize receive either intravenous ketorolac 30 mg bolus follow saline infusion ( Group K ) , intravenous magnesium sulfate 20 mg/kg bolus follow magnesium 2 mg/kg/h ( Group M ) intravenous saline solution 20 ml bolus follow saline infusion entire procedure ( Group S ) . The study use double-blinded methodology random allocation three group use seal opaque envelope number 1 60 , contain instruction study . An independent anesthesiologist involve study prepared solution observer also blind patient 's group record data . In preoperative visit , patient agree participate instructed numeric rating scale ( NRS ) Patient Controlled Analgesia ( PCA ) device . The night surgery , patient premedicated midazolam 7.5 mg per o . Upon arrival operating room , monitor device ( ECG , non-invasive arterial pressure , capnography , pulse oximetry ) bispectral index ( BIS ) monitor establish . An intravenous line secure , general intravenous anesthesia induce target infusion remifentanil propofol . Cisatracurium besylate ( 0.5 mg/kg ) give facilitate tracheal intubation control ventilation adjust maintain normocapnia 50 % oxygen fraction administer . Then , study medication administer bolus 20 minute , follow continuous infusion specific solution , accord study group patient belong , describe . At end surgery , study drug discontinue patient extubated . If patient present clinical sign residual neuromuscular blockade , receive atropine 0.01mg/kg neostigmine 0.04mg/kg . All patient receive dipyrone 30 mg/kg bolus PCA device connect intravenous line discharge Post Anesthesia Care Unit ( PACU ) . PCA solution contain morphine 1mg/ml 0.9 % saline , set give bolus 2ml ( 2mg ) 10min lockout interval . In postoperative period , anesthesiologist responsible study question intensity pain patient use two method : numerical rating scale ( NRS ) ( 0=no pain 10=worst pain imaginable ) descriptive verbal scale ( pain , mild pain , moderate pain severe pain - emergence anesthesia 20 , 30 60 minute , PACU . Patients instructed use PCA device whenever feel pain . Agitation Sedation monitor use RASS scale patient consider sedated RASS â‰¤ -1 . Episodes nausea , vomit , respiratory depression pruritus also record . Patients discharge ward 60 minute , minimum criterion discharge meet . Time ( minute ) first morphine rescue , total consumption morphine PACU register . After 24 hour , pain intensity score , total morphine consumption side effect also record PCA device disconnect .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>ASA III female patient undergo laparoscopic gynecologic oncology surgery , treatment cancer chronic pain , cardiovascular , hepatic renal disease , neuromuscular disease , diabetes , drug alcohol abuse , obesity , patient treat calcium channel blocker magnesium , allergy contraindication drug study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>pain , postoperative</keyword>
	<keyword>anesthesia adjuvant</keyword>
	<keyword>magnesium sulfate</keyword>
</DOC>